Log In
BCIQ
Print this Print this
 

Aldara, Beselna, imiquimod

  Manage Alerts
Collapse Summary General Information
Company Mylan N.V.
Description5% imiquimod cream, an immune response modifier
Molecular Target Toll-like receptor 7 (TLR7)
Mechanism of ActionImmune modulation
Therapeutic ModalitySmall molecule

 Product Details
Disease CategoryStandard IndicationIndication DetailsPartnersMilestonesLatest Stage of DevelopmentRegulatory Designation
 Archive Items are loading loading
Collapse Summary Deals Information
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments

2

$455.0M

$455.0M

0


 Deals Details
DateCompanies InvolvedDeal HeadlineTotal Deal ValueTotal Upfront CashTotal Milestone

11/21/2011

$455.0M

$455.0M

0

05/17/2010

Undisclosed

Undisclosed

0

Get a free BioCentury trial today